Pediatric obesity meeting
This article was originally published in The Gray Sheet
FDA's Pediatric Advisory Committee will discuss clinical trial design and ethical issues related to the evaluation of medical devices intended to treat pediatric obesity at a Nov. 16-17 meeting in Gaithersburg, Md. Devices currently approved for weight loss treatment in adults include Inamed's Lap-Band for laparoscopic adjustable gastric banding. Congress and public advocacy groups have urged FDA to help foster the development or modification of devices for use in children (1"The Gray Sheet" Feb. 14, 2005, p. 10)...
You may also be interested in...
Firms modifying devices for pediatric patients should receive fast-tracked product review, according to a proposal generated by two children's organizations and other stakeholders
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.